Last edition
News about "FDA Approves Additional Treatment for Adults and A"
FDA Approves Additional Treatment for Adults and Adolescents with Hemophilia A or B and Inhibitors
The U.S. Food and Drug Administration today approved Sevenfact [coagulation factor VIIa (recombinant)-jncw] for the treatment and control of bleeding episodes occurring in adults and adolescents 12 years of age and older with hemophilia A or B with inhibitors (neutralizing antibodies)
FDA Approves Additional Treatment For Adults And A | 02/04/2020 | By Darshana | 371
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy